Back to search results
NCT05133245

PHACE - Prospective Genetic Investigation

Enrolling by Invitation
Not specifiedAll AgesObservational
Vanderbilt University Medical Center
~50 participants
Updated 2025-12-23 on ClinicalTrials.gov
What's tested:Diagnostic study only

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Potential PHACE Gene Identification
Measured over 3 years

Conditions

PHACE Syndrome

Explore related trials

PHACE syndrome

Where it's being run

1 sites across 1 states
Tennessee1

Study leadership

  • Karen Joos, MD, PhD · PRINCIPAL_INVESTIGATOR · Vanderbilt Eye Institute

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

PHACE syndrome diagnosis
Must be willing to have an eye examination
Must be willing to undergo genetic testing

Exclusion

No PHACE syndrome diagnosis

What this trial measures

  • Potential PHACE Gene Identification3 years

    Evaluation for potential PHACE gene